Zoledronic Acid Monohydrate CAS 165800-06-6 Dị Ọcha ≥99.0% API Ụlọ Ọrụ Dị Ọcha Dị Elu
Onye nrụpụta nwere ịdị ọcha dị elu yana ogo kwụsiri ike
Aha kemịkalụ: Zoledronic Acid Monohydrate
Ọnọdụ: 165800-06-6
Bisphosphonate siri ike na onye na-eme PKC
API Ogo dị elu, mmepụta azụmahịa
Aha Chemical | Zoledronic acid monohydrate |
Nọmba CAS | 165800-06-6 |
Nọmba CAT | RF-API56 |
Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
Usoro ihe omimi | C5H12N2O8P2 |
Ibu molekụla | 290.1 |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | White ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ kristal ntụ ntụ |
njirimara | IR Spectrum;HPLC ChromatogramUV-Vis: Enwere nnabata kachasị na 210nm |
pH | 2.0-4.0 |
Solubility | Na-agbaze obere n'ime 0.1N sodium hydroxide ngwọta, soluble ntakịrị n'ime mmiri yana 0.1N hydrochloric acid, ihe fọrọ nke nta ka ọ bụrụ ihe na-adịghị ike na ethanol. |
Ịdị ọcha na Agba | Ihe ngwọta kwesịrị ịdị ọcha na enweghị agba;ọ bụrụ na opalescent, ekwesịghị karịa opalescent karịa nkwusioru ntụaka 1;ọ bụrụ na ọ nwere agba, ọ bụghị nnukwu agba karịa Y2 |
Otu adịghị ọcha | ≤0.50% |
Mgbakọta adịghị ọcha | ≤1.0% |
Ọnwụ na ihicha | 5.0% ~ 8.0% |
Chloride | ≤0.02% |
Phosphate | ≤0.50% |
Phosphite | ≤0.50% |
Ọla dị arọ | ≤10ppm |
Ịdị ọcha | ≥99.0% |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | API |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.
Zoledronic acid monohydrate bụ bisphosphonate na-arụ ọrụ nke ukwuu na onye na-arụ ọrụ nke PKC.Zoledronic acid monohydrate bụ heterocyclic bisphosphonate nke a na-ewere na ọ nwere ike kachasị elu nke bisphosphonates maka nkwụsị nke ọkpụkpụ ọkpụkpụ na-arịwanye elu ma jiri ya mee ihe n'ọtụtụ ọmụmụ osteoporosis.Zoledronic acid monohydrate bụ onye na-egbochi ASM na FDPS yana onye na-eme PKC.Zoledronic acid (zoledronate) bụ onye na-egbochi resorption ọkpụkpụ bisphosphonate, onye na-egbochi farnesyl diphosphate (FPP) synthase nke na-ebute nkwụsị ala nke ọrụ osteoclast ma belata nkwụsịtụ ọkpụkpụ na ntụgharị.A na-eji ya agwọ ọrịa osteoporosis postmenopausal, ọrịa Paget, hypercalcemia, yana yana chemotherapy cancer iji gwọọ mmebi ọkpụkpụ nke ọrịa cancer na-agbasa na ọkpụkpụ.